Healio16 小时
FDA approves first new antibiotic for uncomplicated UTIs in nearly 30 years
The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, ...
There’s a New Pill to Treat UTIs
On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...
The American Journal of Managed Care1 天
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
Just 1 in 10 back pain treatments work, study says — what to do instead
Chronic back pain is the most common type of pain, affecting around 16 million American adults — and now a new study has ...
'I'm a GP and you can treat five common spring illnesses at home'
Dr Donald Grant has explained how to tell what illness you have, what precautions you can take and what treatments you can ...
WPSD Local 61 天
Myths and facts about the common cold
You may have heard many tips and tricks for avoiding the common cold — but are they actually preventative or just wishful thinking?
Managed Healthcare Executive13 小时
FDA Approves UTI Antibiotic, Blujepa
Blujepa is the first in a new class of oral antibiotics in 30 years. It is expected to launch in the second half of 2025 in the United States.
Science Daily6 天
Team finds regional, age-related trends in exposure to drug-resistant pathogen
Campylobacter infections are the most common foodborne illnesses in the U.S., sickening an estimated 1.5 million people each year. A new study examined records of Campylobacter jejuni infections from ...